NAICS 541711 · Research And Development In Biotechnology
2 open opportunities · 224 FY2025 awards · $1.26B obligated
Top contractors in this NAICS
- Hoffmann-La Roche INC.$47.5M
- The Emmes Company, LLC$10.7M
- Westat, INC.$3.5M
Hunting recompetes here?
10+ contracts in this NAICS end within 18 months. The largest are listed below — incumbents and end dates included.
All expiring 541711 contracts →Open opportunities
- Development of White Matter Atlases for the Baltimore Longitudinal Study of Aging
- Deadline
- —
- Agency
- —
- Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
- Posted
- Sep 29, 2017
- SHEPHERD 2016
- Deadline
- May 24, 2016
- Agency
- —
- Type
- Presolicitation
- NAICS
- 541711
- Posted
- May 10, 2016
| Title | Agency | Type | NAICS | Posted | Deadline |
|---|---|---|---|---|---|
| Development of White Matter Atlases for the Baltimore Longitudinal Study of Aging | — | Combined Synopsis/Solicitation | 541711 | Sep 29, 2017 | — |
| SHEPHERD 2016 | — | Presolicitation | 541711 | May 10, 2016 | May 24, 2016 |
Largest contracts ending within 18 months
- HHSO100201600038C ↗$47.5M
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002.
- Ends
- Sep 29, 2027
- Started
- Sep 14, 2016
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
- HHSN275201700002C ↗$10.7M
DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
- Ends
- May 27, 2027
- Started
- Jul 27, 2017
- Agency
- National Institutes Of Health
- NAICS
- 541711
- W81XWH15C0048 ↗$3.5M
FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION.
- Ends
- Dec 30, 2026
- Started
- Mar 29, 2015
- Agency
- Defense Health Agency
- NAICS
- 541711
- HHSO100201700016C ↗$2.7M
NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.2.1., ARTICLE C.1., ARTICLE F.4, , ARTICLE G.4. AND THE STATEMENT OF WORK.
- Ends
- Sep 28, 2027
- Started
- Sep 29, 2017
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
- 70RSAT26FR0000002 ↗$2.6M
NEW FFRDC NBACC 2026 INSURANCE
- Ends
- Mar 17, 2027
- Started
- Mar 18, 2026
- Agency
- Office Of Procurement Operations
- NAICS
- 541711
- 70RSAT26FR0000017 ↗$2.0M
NBACC II EXTENSION WORK FOR OTHERS (WFO) TASK ORDER FOR THE EQUIPMENT ACQUISITION AND DEMONSTRATION PROJECT PLANNING FOR GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING (GUIDE), PHASE II.
- Ends
- Jul 1, 2027
- Started
- Jul 2, 2026
- Agency
- Office Of Procurement Operations
- NAICS
- 541711
- 75N93024F00002 ↗$1.7M
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES
- Ends
- Jun 23, 2027
- Started
- Jun 24, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541711
- 70RSAT25FR0000014 ↗$797K
SECTION 2(D) - TO AWARD AND FULLY FUND THE NATIONAL BIODEFENSE ANALYSIS AND COUNTERMEASURES CENTER (NBACC) ANALYTIC TASK (AT) FOR STERILIZED LAB WASTE DISPOSAL AND SITE SERVICES FOR 2025 (THE NBACC II EXTENSION).
- Ends
- Nov 29, 2026
- Started
- May 15, 2025
- Agency
- Office Of Procurement Operations
- NAICS
- 541711
- 75N93024F00001 ↗$716K
PRECLINICAL MODELS OF INFECTIOUS DISEASES
- Ends
- Jul 9, 2027
- Started
- Jul 10, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541711
- 75N93022F00001 ↗$564K
TASK A68 SCREENING VACCINE (AND OTHER BIOLOGICS) PLATFORM TECHNOLOGIES USING CORONAVIRUS MOUSE IMMUNOGENICITY AS A MODEL SYSTEM
- Ends
- Nov 29, 2026
- Started
- May 22, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541711
| PIID | Contractor | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|---|
| HHSO100201600038C ↗ | Hoffmann-La Roche INC. | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. | Office Of Assistant Secretary For Preparedness And Response | 541711 | $47.5M | Sep 14, 2016 | Sep 29, 2027 |
| HHSN275201700002C ↗ | The Emmes Company, LLC | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT | National Institutes Of Health | 541711 | $10.7M | Jul 27, 2017 | May 27, 2027 |
| W81XWH15C0048 ↗ | Westat, INC. | FREEZE DRIED PLASMA CLINICAL TRIAL FOR BLA RESUBMISSION. | Defense Health Agency | 541711 | $3.5M | Mar 29, 2015 | Dec 30, 2026 |
| HHSO100201700016C ↗ | Regeneron Pharmaceuticals INC | NO COST MOD TO REVISE THE CONTRACT SECTIONS: ARTICLE B.2.1., ARTICLE C.1., ARTICLE F.4, , ARTICLE G.4. AND THE STATEMENT OF WORK. | Office Of Assistant Secretary For Preparedness And Response | 541711 | $2.7M | Sep 29, 2017 | Sep 28, 2027 |
| 70RSAT26FR0000002 ↗ | Battelle National Biodefense Institute, LLC | NEW FFRDC NBACC 2026 INSURANCE | Office Of Procurement Operations | 541711 | $2.6M | Mar 18, 2026 | Mar 17, 2027 |
| 70RSAT26FR0000017 ↗ | Battelle National Biodefense Institute, LLC | NBACC II EXTENSION WORK FOR OTHERS (WFO) TASK ORDER FOR THE EQUIPMENT ACQUISITION AND DEMONSTRATION PROJECT PLANNING FOR GENERATIVE UNCONSTRAINED INTELLIGENT DRUG ENGINEERING (GUIDE), PHASE II. | Office Of Procurement Operations | 541711 | $2.0M | Jul 2, 2026 | Jul 1, 2027 |
| 75N93024F00002 ↗ | University Of Texas Medical Branch At Galveston | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES | National Institutes Of Health | 541711 | $1.7M | Jun 24, 2024 | Jun 23, 2027 |
| 70RSAT25FR0000014 ↗ | Battelle National Biodefense Institute, LLC | SECTION 2(D) - TO AWARD AND FULLY FUND THE NATIONAL BIODEFENSE ANALYSIS AND COUNTERMEASURES CENTER (NBACC) ANALYTIC TASK (AT) FOR STERILIZED LAB WASTE DISPOSAL AND SITE SERVICES FOR 2025 (THE NBACC II EXTENSION). | Office Of Procurement Operations | 541711 | $797K | May 15, 2025 | Nov 29, 2026 |
| 75N93024F00001 ↗ | Trustees Of Tufts College | PRECLINICAL MODELS OF INFECTIOUS DISEASES | National Institutes Of Health | 541711 | $716K | Jul 10, 2024 | Jul 9, 2027 |
| 75N93022F00001 ↗ | University Of North Carolina At Chapel Hill | TASK A68 SCREENING VACCINE (AND OTHER BIOLOGICS) PLATFORM TECHNOLOGIES USING CORONAVIRUS MOUSE IMMUNOGENICITY AS A MODEL SYSTEM | National Institutes Of Health | 541711 | $564K | May 22, 2022 | Nov 29, 2026 |